REQUEST A DEMO
Total
USD $0.00
Search more companies

Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Humanwell Healthcare (Group) Co.,Ltd. Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Humanwell Healthcare ( Group) Co., is a pharmaceutical company that specializes in soft capsule drug formulations and claims to be a supplier in the US market. The company was the first soft capsule production enterprise in Hubei Province to obtain US FDA certification. Humanwell Healthcare ( Group) Co., provides services including new drug research, development, clinical trials, and registration, supported by a team of pharmaceutical experts. The company has expanded its operations internationally, with production facilities in Mali, Africa.

Headquarters
No. 666, Gaoxin Avenue, East Lake High-tech Zone, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430075

Contact Details: Purchase the Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report to view the information.

Website: http://www.humanwell.com.cn

Basic Information
Total Employees:
Purchase the Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report to view the information.
Outstanding Shares:
Purchase the Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report to view the information.
Registered Capital:
Purchase the Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report to view the information.
Financial Auditors:
Purchase the Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report to view the information.
Incorporation Date:
March 30, 1993
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
11.7%
Purchase this report to view the information.
8.02%
Purchase this report to view the information.
6%
Purchase this report to view the information.
5.31%
Purchase this report to view the information.
3.67%
Subsidiaries
Beijing Haitai United Pharmaceutical Technology Development Co., Ltd.
100%
Beijing Renfu Medical Equipment Co., Ltd.
100%
Beijing Saisvade Biotechnology Co., Ltd
100%
Company Performance
Financial values in the chart are available after Humanwell Healthcare (Group) Co.,Ltd. (人福医药集团股份公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.58%
Total operating revenue
-6.64%
Operating Profit/Loss (EBIT)
1.62%
Net Profit/Loss for the Period
3.59%
Total Assets
-1.4%
Total Equity
4.19%
Operating Profit Margin (ROS)
1.22%
Net Profit Margin
1.2%
Return on Equity (ROE)
-0.06%
Debt/Equity
-1.03%
Quick Ratio
0.19%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?